Pandemic Innovation Conference to host startups and investors online

OurCrowd, the large venture investment platform, will host the OurCrowd Pandemic Innovation Conference on 22nd June to explore the latest technological solutions to the coronavirus crisis, including vaccination, treatment, diagnostics and prevention of the disease.

The sessions will also cover non-healthcare innovations addressing the changing nature of work and life brought about by the ‘Pandemic Pivot’ occurring in the global economy. The online conference will also introduce OurCrowd’s new $100m Pandemic Innovation Fund, which will invest in compelling startups addressing the societal and medical realities of pandemics. Investors from over one hundred countries are expected to attend online, including some of the world's biggest investors.

The online conference will be broadcast from TV studios in Israel and will feature investors, entrepreneurs, medical experts and business leaders from around the world. Online attendees will be able to meet directly with startup CEOs and topic experts in online breakout sessions. There will be live Q&As with guest speakers and the chance to network with other attendees from around the world in real time. As an added bonus, the conference will close with the premiere of 'When The World Stops Ending', the new music video by viral music sensation, Dave Carroll.

The Conference will build upon the excitement and the crowd that was present at the OurCrowd Global Investor Summit this past February. According to the company, the Summit, held annually in Jerusalem, is Israel’s largest business event and the largest crowdfunding event in the world, which this year saw more than 23,000 registered to attend from around the world. Thousands of attendees are expected to join the OurCrowd Pandemic Innovation Conference online on 22nd June.

“This conference is about providing global investor support to the remarkable entrepreneurs who are on the front lines working hard to solve the problems humanity is facing with the Pandemic. These entrepreneurs are racing to the vaccine, are building faster and more accurate testing, developing new therapeutics, and delivering remote healthcare services. These people and their companies need the resources of far-sighted investors so they can help to fix the world,” said OurCrowd CEO, Jon Medved.

Alec Ellison, OurCrowd’s US Chairman, added: “It’s not just medical companies that we will highlight at the Pandemic Innovation conference. The post-COVID world will look different and require innovative technology solutions, whether it’s working from home, distance learning, increased cyber security, robotic process automation - these will all be part of our 'new normal' and will be featured front and centre at the Conference.”

Featured Experts:

  • Dr. Paul Rothman, CEO, Johns Hopkins Medicine
  • Professor Joseph M. Jacobson, Head, MIT Molecular Machines Research Group
  • Dr. Ruth Atherton, Director, Bill & Melinda Gates Foundation
  • Scott Bessent, Founder & CIO, Key Square Group; Former CIO, Soros Fund Mgmt
  • Jeremy Levine, Partner, Bessemer Venture Partners
  • Deven Parekh, Managing Director, Insight Venture Partners
  • Jon Medved, CEO, OurCrowd

Among the topics to be addressed are:

  • The Race for a Vaccine: Top researchers such as Prof. Joseph Jacobson, Head, MIT Molecular Machines Research Group and entrepreneurs such as Sigal Tal, Chief Medical Officer of MigVax, vaccine startup
  • Meeting the Challenge of a Global Pandemic: From testing and treatment to remote work and cyber security, experts from tech, business, and government, such as Ruth Atherton, Director, Bill & Melinda Gates Foundation, and Dr. Paul Rothman, CEO Johns Hopkins Medicine, weigh in on what’s to come
  • The Top 10 Pandemic Tech Trends: Stav Erez, Partner Labs/02 accelerator, and telemedicine entrepreneur Dr. Jonathan Wiesen, reveal what will be hot and actionable going forward in a changed world
  • Investing in a Time of Crisis: Three of the world’s top investors, Scott Bessent, Founder & CIO, Key Square Group; Jeremy Levine, Partner, Bessemer Venture Partners; and Deven Parekh, Managing Director, Insight Venture Partners provide exclusive insights into ensuring your portfolio survives and thrives during a global challenge

Among the startups showcased are:

  • data.world - the largest open data community, created a dedicated hub for up-to-date COVID-19 data so members can work together to fight the pandemic. The company’s cloud-native enterprise data catalogue maps siloed data to business concepts, creating a body of knowledge anyone can find, understand, and use.
  • Ripple - Makes a great-tasting, high protein, plant-based alternative to dairy that addresses the need for food supply chain continuity during the pandemic and beyond.
  • SaNOtize - Approved by Health Canada for multi-centre Phase II trial of its Nitric Oxide Releasing Solution (NORSTM) for the prevention and early treatment of COVID-19.
  • Sight Diagnostics - Compact complete blood count analyser that provides lab-grade results with two drops of finger prick blood sample in under ten minutes.
  • Barcode Diagnostics - Multiple-screening platform for detection of SARS-CoV-2 infection in large populations, using individualised barcoding technology.
  • Trellis - delivers Autonomous Food Supply Chains powered by smart data and AI. Its Cloud/AI SaaS platform helps food & beverage producers to integrate data from field to market to eliminate agriculture waste and boost production efficiency in order to conserve global resources.
  • MigVax - Developing the MigVax-101 COVID-19 oral subunit vaccine for humans based on a proven platform developed over four years that was shown to be a highly effective oral vaccine against IBV (Infectious Bronchitis Virus) in poultry.

The conference will be streamed across several time zones with two start times so that attendees around the world will be able to join. Registration provides access to both. Content will be the same for both broadcasts.

  • Eastern Hemisphere: London: 7am-10am | Jerusalem: 9am-12pm | India: 11:30am-2:30pm | Hong Kong: 2pm-5pm | Sydney: 4pm-7pm
  • Western Hemisphere: San Francisco: 8am-11am | New York: 11am-2pm | London: 4pm-7pm | Jerusalem: 6pm-9pm

 Register now.

Startup Details

Startup Details

TOTAL FUNDING AMOUNT $112.5M
CB RANK (COMPANY)

OurCrowd

OurCrowd is a global crowd investing platform for accredited investors.

OurCrowd sources deals, performs due diligence, and opens investments to its members, leading every investment with its own money. It takes an active stake in the companies it finances, through board seats and a mentorship program that pairs startups with OurCrowd contacts from relevant industries.

  • Headquarters Regions
    Jerusalem, Yerushalayim, Israel
  • Founded Date
    Feb 1, 2013
  • Founders
    Jonathan Medved, Steven Blumgart
  • Operating Status
    Active
  • Number of Employees
    101-250